Xenetic Biosciences (XBIO) Competitors $2.74 -0.11 (-3.70%) As of 05/1/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsOwnershipSEC FilingsShort InterestTrendsBuy This Stock XBIO vs. LPTX, BIVI, MIRA, GLYC, ABVC, NRSN, COCP, PHIO, CLRB, and MEShould you be buying Xenetic Biosciences stock or one of its competitors? The main competitors of Xenetic Biosciences include Leap Therapeutics (LPTX), BioVie (BIVI), MIRA Pharmaceuticals (MIRA), GlycoMimetics (GLYC), ABVC BioPharma (ABVC), NeuroSense Therapeutics (NRSN), Cocrystal Pharma (COCP), Phio Pharmaceuticals (PHIO), Cellectar Biosciences (CLRB), and 23andMe (ME). These companies are all part of the "pharmaceutical preparations" industry. Xenetic Biosciences vs. Leap Therapeutics BioVie MIRA Pharmaceuticals GlycoMimetics ABVC BioPharma NeuroSense Therapeutics Cocrystal Pharma Phio Pharmaceuticals Cellectar Biosciences 23andMe Xenetic Biosciences (NASDAQ:XBIO) and Leap Therapeutics (NASDAQ:LPTX) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, institutional ownership, earnings, profitability, analyst recommendations, dividends, valuation, risk and community ranking. Which has better valuation & earnings, XBIO or LPTX? Xenetic Biosciences has higher revenue and earnings than Leap Therapeutics. Xenetic Biosciences is trading at a lower price-to-earnings ratio than Leap Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioXenetic Biosciences$2.50M1.71-$4.14M-$2.57-1.08Leap TherapeuticsN/AN/A-$81.41M-$1.84-0.23 Does the MarketBeat Community prefer XBIO or LPTX? Leap Therapeutics received 120 more outperform votes than Xenetic Biosciences when rated by MarketBeat users. Likewise, 68.37% of users gave Leap Therapeutics an outperform vote while only 66.92% of users gave Xenetic Biosciences an outperform vote. CompanyUnderperformOutperformXenetic BiosciencesOutperform Votes17466.92% Underperform Votes8633.08% Leap TherapeuticsOutperform Votes29468.37% Underperform Votes13631.63% Which has more volatility and risk, XBIO or LPTX? Xenetic Biosciences has a beta of 2.3, meaning that its share price is 130% more volatile than the S&P 500. Comparatively, Leap Therapeutics has a beta of 0.22, meaning that its share price is 78% less volatile than the S&P 500. Does the media prefer XBIO or LPTX? In the previous week, Leap Therapeutics had 1 more articles in the media than Xenetic Biosciences. MarketBeat recorded 2 mentions for Leap Therapeutics and 1 mentions for Xenetic Biosciences. Xenetic Biosciences' average media sentiment score of 1.89 beat Leap Therapeutics' score of 0.93 indicating that Xenetic Biosciences is being referred to more favorably in the media. Company Overall Sentiment Xenetic Biosciences Very Positive Leap Therapeutics Positive Do analysts prefer XBIO or LPTX? Leap Therapeutics has a consensus price target of $4.92, suggesting a potential upside of 1,084.17%. Given Leap Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe Leap Therapeutics is more favorable than Xenetic Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Xenetic Biosciences 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Leap Therapeutics 0 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.25 Is XBIO or LPTX more profitable? Leap Therapeutics has a net margin of 0.00% compared to Xenetic Biosciences' net margin of -161.63%. Xenetic Biosciences' return on equity of -49.51% beat Leap Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Xenetic Biosciences-161.63% -49.51% -43.99% Leap Therapeutics N/A -116.24%-93.18% Do insiders and institutionals have more ownership in XBIO or LPTX? 15.1% of Xenetic Biosciences shares are held by institutional investors. Comparatively, 30.5% of Leap Therapeutics shares are held by institutional investors. 14.7% of Xenetic Biosciences shares are held by insiders. Comparatively, 5.4% of Leap Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. SummaryLeap Therapeutics beats Xenetic Biosciences on 10 of the 17 factors compared between the two stocks. Get Xenetic Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for XBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart XBIO vs. The Competition Export to ExcelMetricXenetic BiosciencesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.27M$6.84B$5.53B$7.93BDividend YieldN/A3.05%5.11%4.22%P/E Ratio-1.047.3222.5918.54Price / Sales1.71241.43401.35103.29Price / CashN/A65.8538.1834.62Price / Book0.446.486.774.25Net Income-$4.14M$143.41M$3.22B$248.18M7 Day Performance0.51%2.58%1.39%1.03%1 Month Performance3.75%5.00%2.78%2.70%1 Year Performance-28.97%-3.72%15.85%4.05% Xenetic Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)XBIOXenetic Biosciences1.2434 of 5 stars$2.77-2.5%N/A-31.9%$4.27M$2.50M-1.044Upcoming EarningsPositive NewsLPTXLeap Therapeutics2.4458 of 5 stars$0.36-1.0%$4.92+1,267.3%-87.3%$14.84MN/A-0.1940Gap DownBIVIBioVie2.6546 of 5 stars$0.79-5.6%$3.00+277.8%+74.8%$14.65MN/A-0.0810Short Interest ↓Gap UpMIRAMIRA Pharmaceuticals2.8513 of 5 stars$0.87-7.9%$14.00+1,518.5%+39.1%$14.54MN/A-1.542Short Interest ↓GLYCGlycoMimetics2.0954 of 5 stars$0.22-1.3%N/A-83.8%$14.19M$10,000.00-0.3750Upcoming EarningsAnalyst ForecastShort Interest ↓News CoverageABVCABVC BioPharma0.7557 of 5 stars$0.87+2.1%N/A-8.8%$13.77M$509,788.00-1.0130Earnings ReportPositive NewsGap UpNRSNNeuroSense Therapeutics1.1229 of 5 stars$1.00-3.2%N/A-17.6%$13.67MN/A-1.5610Short Interest ↓Gap DownCOCPCocrystal Pharma2.4848 of 5 stars$1.34+1.9%$7.00+424.2%+3.9%$13.58MN/A-0.7210PHIOPhio Pharmaceuticals2.5188 of 5 stars$2.83+3.7%$4.00+41.3%-72.3%$13.52MN/A-0.2610Upcoming EarningsCLRBCellectar Biosciences1.7425 of 5 stars$0.29-2.9%$12.50+4,207.4%-91.6%$13.37MN/A-0.1710Gap UpME23andMeN/A$0.50-35.3%N/A-95.0%$13.36M$208.78M-0.03770Gap DownHigh Trading Volume Related Companies and Tools Related Companies LPTX Competitors BIVI Competitors MIRA Competitors GLYC Competitors ABVC Competitors NRSN Competitors COCP Competitors PHIO Competitors CLRB Competitors ME Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:XBIO) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xenetic Biosciences Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Xenetic Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy XBIO Stock Free XBIO Stock Alerts